Sellas Life Sciences Group Inc (SLS) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 3.00
(+125.56%)
Based on the Sellas Life Sciences Group Inc stock forecast from 1 analysts, the average analyst target price for Sellas Life Sciences Group Inc is USD 3.00 over the next 12 months. Sellas Life Sciences Group Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sellas Life Sciences Group Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Sellas Life Sciences Group Inc’s stock price was USD 1.33. Sellas Life Sciences Group Inc’s stock price has changed by -8.90% over the past week, +1.53% over the past month and -13.64% over the last year.
No recent analyst target price found for Sellas Life Sciences Group Inc
No recent average analyst rating found for Sellas Life Sciences Group Inc
Company Overview Sellas Life Sciences Group Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Sellas Life Sciences Group Inc (SLS)
Loading...
Unadjusted Closing Price for Sellas Life Sciences Group Inc (SLS)
Loading...
Share Trading Volume for Sellas Life Sciences Group Inc Shares
Loading...
Compare Performance of Sellas Life Sciences Group Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for SLS
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Sellas Life Sciences Group Inc (Sector: Biotechnology )
Frequently Asked Questions About Sellas Life Sciences Group Inc (SLS) Stock
Based on ratings from 1 analysts Sellas Life Sciences Group Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on SLS's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for SLS is USD 3.00 over the next 12 months. The maximum analyst target price is USD 3 while the minimum anlayst target price is USD 3.
SLS stock's Price/Earning ratio is 3.37.
Our analysis grades SLS stock's Price / Earning ratio at F. This means that SLS stock's Price/Earning ratio is above 41% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this SLS may be fairly valued for its sector
The last closing price of SLS's stock was USD 1.33.
The most recent market capitalization for SLS is USD 0.08B.
Based on targets from 1 analysts, the average taret price for SLS is projected at USD 3.00 over the next 12 months.
This means that SLS's stock price may go up by +125.56% over the next 12 months.
We can't find any ETFs which contains Sellas Life Sciences Group Inc's stock.
Sorry, we do not have any data on the number of employees for Sellas Life Sciences Group Inc.
Sorry we do not have any infomation available on Sellas Life Sciences Group Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SLS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
